跳至主要内容
临床试验/NCT02379702
NCT02379702已完成不适用

Turkey Metabolic Syndrome Prevalence Study - METSAR II

Abdi Ibrahim Ilac San. ve Tic A.S.6 个研究点 分布在 1 个国家目标入组 1,659 人开始时间: 2014年6月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
1,659
试验地点
6
主要终点
comorbidities and changes in general health

研究概览

简要总结

Following the first study conducted to investigate the prevalence of metabolic syndrome and its components in Turkey, it was aimed to demonstrate the change in general health condition of available patients after the period of time lapsed. This study will provide important information on the social and economic dimensions of metabolic syndrome and will contribute to development of preventive programs.

详细描述

In the first METSAR-I study conducted in 2003, metabolic syndrome screening was made by two different team. Participants were visited at their addresses and informed about the research study and gave written consent. They were invited on an empty stomach for hospital visit on the day after. Pre-trained nurses completed the forms of patients during that second visit. After 11 years, a questionnaire by telephone survey will be applied to patients who participated in the METSAR-II study. The main goal is to determine the changes of metabolic syndrome population during that period.

研究设计

研究类型
Observational
时间视角
Prospective

入排标准

性别
All
接受健康志愿者

入选标准

  • Volunteers who participated in the METSAR-I study in 2003
  • Patients who accepted to participate will be included the second follow up phase.

排除标准

  • 未提供

结局指标

主要结局

comorbidities and changes in general health

时间窗: 10 year

次要结局

未报告次要终点

研究者

发起方
Abdi Ibrahim Ilac San. ve Tic A.S.
申办方类型
Industry
责任方
Sponsor

研究点 (6)

Loading locations...

相似试验